Injective (INJ) is currently trading at $3.39, reflecting a slight 24-hour change of 0.72%. The price has fluctuated within a daily range of $3.30 to $3.45, indicating a relatively stable short-term trading environment.

The trading volume over the last 24 hours stands at approximately $75 million, representing 22.06% of its market cap, which suggests healthy market activity. The hourly moving averages indicate a mixed sentiment; while the 21 SMA shows a slight upward momentum (+0.25%), the 8 and 13 SMAs indicate short-term declines of -0.53% and -0.55%, respectively.

Momentum indicators support a cautious bullish outlook, with the 1-hour RSI at 60 and the 7-day RSI at 58, both suggesting the asset is neither overbought nor oversold. Furthermore, the 7-day and 14-day price changes of 13.8% and 19.8%, respectively, indicate positive short-term trends, although the 30-day change of 5.07% suggests some consolidation.

The all-time high for INJ was $52.62, achieved in March 2024, indicating significant long-term upside potential. However, the current price is significantly lower than this peak, suggesting that while there is room for growth, the market sentiment must improve to approach historical highs.

Given the current price action, mixed moving averages, and moderate momentum indicators, the recommendation is to **Hold**. This rating reflects an assessment that while there is potential for upward movement, the mixed signals suggest waiting for clearer bullish confirmation before increasing positions.